APOC3 Gene and Metabolic Syndrome
Author Information
Author(s): Rebecca L Pollex, Matthew R Ban, T Kue Young, Peter Bjerregaard, Sonia S Anand, Salim Yusuf, Bernard Zinman, Stewart B Harris, Anthony JG Hanley, Philip W Connelly, Murray W Huff, Robert A Hegele
Primary Institution: Robarts Research Institute
Hypothesis
The study aims to examine the APOC3 -455T>C and INSIG2 rs7566605 polymorphisms as potential genetic determinants for metabolic syndrome in a multi-ethnic sample.
Conclusion
The APOC3 -455T>C polymorphism is associated with an increased risk of metabolic syndrome, while the INSIG2 rs7566605 polymorphism is not.
Supporting Evidence
- Carriers of ≥1 copy of APOC3 -455C were more likely to have metabolic syndrome than noncarriers.
- The prevalence of metabolic syndrome was 22.6% in the overall study population.
- The association was related to higher triglyceride and lower HDL cholesterol levels.
Takeaway
This study found that a specific gene variant can make people more likely to have metabolic syndrome, which is a group of health problems that increase the risk of heart disease and diabetes.
Methodology
Subjects were genotyped for both the APOC3 -455T>C and INSIG2 rs7566605 polymorphisms and classified for the presence or absence of metabolic syndrome.
Limitations
Fewer subjects had DNA available for INSIG2 genotyping.
Participant Demographics
The study included Inuit from Greenland and Canada, Oji-Cree, and Canadians of South Asian, Chinese, and European descent.
Statistical Information
P-Value
p<0.0001
Confidence Interval
95% CI 1.40 to 2.14
Statistical Significance
p<0.0001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website